Hydroxychloroquine prophylaxis for COVID-19 contacts in India.

Rathi, Sahaj; Ish, Pranav; Kalantri, Ashwini; Kalantri, Shriprakash

Rathi, Sahaj; Ish, Pranav; Kalantri, Ashwini; Kalantri, Shriprakash.

Rathi S; Department of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102, India.
Ish P; Department of Pulmonary Medicine, Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Kalantri A; Department of Community Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102, India.
Kalantri S; Department of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102, India. Electronic address: sp.kalantri@gmail.com.

Lancet Infect Dis ; 20(10): 1118-1119, 2020 10.

Article in English | MEDLINE | ID: covidwho-72034

Subject(s)

Coronavirus Infections/prevention & control; Hydroxychloroquine/therapeutic use; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Pre-Exposure Prophylaxis; Betacoronavirus; COVID-19; Chloroquine/supply & distribution; Chloroquine/therapeutic use; Contact Tracing; Coronavirus Infections/drug therapy; Family Characteristics; Humans; Hydroxychloroquine/supply & distribution; India; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Pre-Exposure Prophylaxis / Hydroxychloroquine Type of study: Observational study Limits: Humans Country/Region as subject: Asia Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: S1473-3099(20)30313-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google